New oral vaccine succeeds against multiple cholera strains offering promise for broad use in endemic regions
New oral vaccine succeeds against multiple cholera strains offering promise for broad use in endemic regions
New antibody therapeutic enters Phase 1 with hopes of helping women with hot flashes and night sweats
Mid-stage results show meaningful reductions in pathological protein, setting stage for later-phase trials
Combination of avutometinib and defactinib offers new option where chemotherapy has often failed
TRANQUILITY trial results strengthen case for pacibekitug as a potential quarterly IL-6 inhibitor for cardiovascular inflammation in chronic …
Dual clinical studies reveal statistically meaningful benefits for patients with MSA, highlighting a leap forward for disease-modifying treatment …
Phase III ASCENT-04/KEYNOTE-D19 trial reveals meaningful PFS improvement with a novel antibody-drug conjugate/immunotherapy combo
Enhertu combo shows promise in metastatic breast cancer while Arvinas reveals hopeful data on a novel lymphoma proteolysis …
A key regulation is poised to reshape clinical research in Britain—reducing red tape, elevating patient voices and strengthening …
New data reveals that smaller biopharma players are gaining ground in innovation, contributing a growing share of first-in-class …
Already a subscriber? Log in